Newsletter
At Sectoral Asset Management, our goal and ambition is to provide you with a full range of investment advisory services. With an established track record in managing biotechnology equity portfolios and several years of experience in the biotechnology and pharmaceutical sectors, we intend to offer you not only our portfolio management services but also to share some of our expertise with you.
The purpose of the Sectoral Newsletter is to provide you with a quarterly update on our views on healthcare equities and to discuss in detail some of the fundamental issues facing investors in this sector.
We hope you will find the Sectoral Newsletter enjoyable and useful for your investing purposes. |
|
| Stay up to date with the latest investment trends. | |
| 2010 |
|
Q2: Hepatitis C: Overview of a Rapidly Evolving Therapeutic Area Q1: Investing in Biotechnology |
| 2009 |
|
Q4: Healthcare Investment Opportunities in India Q3: The Emerging Market Opporunity for Global Pharmaceuticals Q2: Diabetes and the GLP-1 Based Therapies Q1: Targeting Bone Remodeling: Novel |
| 2008 |
|
Q4: Second Generation Monoclonal Antibodies Q3: Healthcare Investment Opportunities in Russia Q2: Diabetes and the GLP-1 Based Therapies Q1: The rise of MRSA |
| 2006 |
|
Q4: Emerging Approaches to Multiple Sclerosis Therapy Q3: MedTech, Transitioning to New Heights Q2: Biotech Taking a Swing at Stroke (again...) Q1: Roche's CERA: Our Hepotheses |